Literature DB >> 5961439

Metabolic studies of tetrabenazine, a psychotropic drug in animals and man.

D E Schwartz, H Bruderer, J Rieder, A Brossi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5961439     DOI: 10.1016/0006-2952(66)90031-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Tetrabenazine: for chorea associated with Huntington's disease.

Authors:  Lesley J Scott
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 2.  Vesicular monoamine transporter 2: role as a novel target for drug development.

Authors:  Guangrong Zheng; Linda P Dwoskin; Peter A Crooks
Journal:  AAPS J       Date:  2006-11-10       Impact factor: 4.009

3.  Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors.

Authors:  Zhangyu Yao; Xueying Wei; Xiaoming Wu; Jonathan L Katz; Theresa Kopajtic; Nigel H Greig; Hongbin Sun
Journal:  Eur J Med Chem       Date:  2011-02-23       Impact factor: 6.514

4.  Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine.

Authors:  D Scherman; P Jaudon; J P Henry
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders.

Authors:  M S Roberts; S McLean; K S Millingen; H M Galloway
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 6.  Synthesis of Tetrabenazine and Its Derivatives, Pursuing Efficiency and Selectivity.

Authors:  Seung-Mann Paek
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.